Affiliations: [a] Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany | [b] Outpatient Clinic for Gastroenterology, Bonn, Germany | [c] Institute for Human Genetics, University Hospital Bonn, University of Bonn, Bonn, Germany | [d] Institute for Pathology, University Hospital Bonn, University of Bonn, Bonn, Germany
Correspondence:
[*]
Corresponding author: Dr. med. Frank Grünhage, Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Sigmund-Freud-Str. 25, 53105 Bonn, Germany. Tel.: +49 228 287 15507; Fax: +49 228 287 14698; E-mail: [email protected].
Abstract: Mutations of the base excision repair gene MUTYH have been reported as underlying genetic defects in autosomal-recessive familial adenomatous polyposis (FAP). Our aim was to determine the frequency of the most common mutations (p.Tyr165Cys and p.Gly382Asp) in patients with strong evidence for familial colorectal cancer (fCRC). Methods:We recruited 93 patients with fCRC but no indication for monogenic CRC syndromes (FAP, hereditary non-polyposis colorectal cancer). Tumors showed regular expression of MLH1 and MSH2, and microsatellite instability was excluded. Sporadic CRC patients (n=93) and ‘hyper-normal’ controls without any adenomas in screening colonoscopies (n=93) were studied for comparison. Results:In the fCRC group, two patients carried biallelic mutations (p.Tyr165Cys/p.Tyr165Cys, p.Tyr165Cys/p.Gly382Asp), while four patients displayed a heterozygous genotype (3 × p.Tyr165Cys/wt, 1 × p.Gly382Asp/wt). In contrast, only two p.Gly382Asp/wt patients were detected in the sporadic CRC group and one p.Gly382Asp carrier was observed in ‘hyper-normal’ controls, and the p.Tyr165Cys risk allele was absent in both control groups. Association tests demonstrated an increased odds ratio (OR) for CRC in carriers of the p.Tyr165Cys risk allele among fCRC patients, as compared to sporadic CRC patients and controls (OR 2.38; p=0.03). Conclusions:In our cohort the prevalence of pathogenic MUTYH mutations was increased among fCRC patients compared to sporadic CRC and controls. The association of the p.Tyr165Cys mutation with fCRC indicates that this variant represents a susceptibility factor in a defined subgroup of CRC patients with a positive family history.
